Pavmed logo

Pavmed Share Price (NASDAQ: PAVM)

$0.48

0.01

(2.13%)

Live

Last updated on

Check the interactive Pavmed Stock chart to analyse performance

Pavmed Inc Key Stats

Check Pavmed key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.47
Open
$0.4338
Market Capitalization
$10.3M
Today's Volume
$386.0K
Revenue TTM
$1.0M
EBITDA
$-26.6M
Earnings Per Share (EPS)
$4.41
PE Ratio
0.11
Profit Margin
7144.8%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
10.67%

Stock Returns calculator for Pavmed Stock including INR - Dollar returns

The Pavmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pavmed investment value today

Current value as on today

₹63,594

Returns

₹36,406

(-36.41%)

Returns from Pavmed Stock

₹40,741 (-40.74%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Pavmed Stock

7%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Pavmed Stock from India on INDmoney has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pavmed Inc

  • Name

    Holdings %

  • First Manhattan Co. LLC

    3.55%

  • Geode Capital Management, LLC

    0.46%

  • Vanguard Group Inc

    0.40%

  • BlackRock Inc

    0.36%

  • CapTrust Financial Advisors

    0.32%

  • LPL Financial Corp

    0.28%

Analyst Recommendation on Pavmed Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Pavmed(by analysts ranked 0 to 5 stars)

Pavmed Share Price Target

What analysts predicted

Upside of 2087.5%

Target:

$10.50

Current:

$0.48

Pavmed share price target is $10.50, a slight Upside of 2087.5% compared to current price of $0.48 as per analysts' prediction.

Pavmed Stock Insights

  • Price Movement

    In the last 7 days, PAVM stock has moved up by 8.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 8.0K → 6.0M (in $), with an average increase of 99.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 18.96M → -11.92M (in $), with an average decrease of 162.9% per quarter
  • PAVM vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 34.1% return, outperforming this stock by 70.3%
  • PAVM vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 154.1% return, outperforming this stock by 251.7%
  • Price to Sales

    ForPAVM every $1 of sales, investors are willing to pay $6.1, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Pavmed Technicals Summary

Sell

Neutral

Buy

Pavmed is currently in a neutral trading position according to technical analysis indicators.

Pavmed Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pavmed Inc logo
-17.92%
-41.61%
-42.15%
-97.5%
-98.43%
Medtronic Plc logo
0.8%
2.82%
3.77%
3.67%
-10.92%
Edwards Lifesciences Corp. logo
4.26%
12.47%
19.03%
-10.31%
0.38%
Boston Scientific Corp. logo
0.31%
1.71%
33.6%
162.02%
169.81%
Stryker Corporation logo
-1.61%
1.62%
11.27%
90.44%
108.57%
Abbott Laboratories logo
4.94%
-1.75%
17.65%
30.12%
28.49%

About Pavmed Inc

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York
Organization
Pavmed
Employees
39
CEO
Dr. Lishan Aklog M.D.
Industry
Health Technology

Key Management of Pavmed Inc

NameTitle
Dr. Lishan Aklog M.D.
Chairman & CEO
Mr. Dennis M. McGrath CPA
President & CFO
Mr. Shaun M. O'Neill M.B.A.
Executive VP & COO
Mr. Michael Adam Gordon
Executive VP, General Counsel & Secretary
Dr. Brian J. deGuzman M.D.
Executive VP, Chief Technology & Compliance Officer
Dr. Suman M. Verma M.D., Ph.D.
Senior VP of Molecular Genetics & Chief Scientific Officer
Dr. Deepika A. Lakhani Ph.D.
Senior VP, Chief Regulatory & Quality Officer
Dr. Victoria T. Lee M.D.
Senior VP & Chief Medical Officer

Important FAQs about investing in PAVM Stock from India :

What is Pavmed share price today?

Pavmed share price today is $0.48 as on . Pavmed share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Pavmed share?

Pavmed share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Pavmed stock price today i.e. is trending at $0.48, lower by 74.74% versus the 52 week high.

How to invest in Pavmed Stock (PAVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pavmed on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pavmed Shares that will get you 3.1250 shares as per Pavmed share price of $0.48 per share as on August 25, 2025 at 7:38 PM IST.

What is the minimum amount required to buy Pavmed Stock (PAVM) from India?

Indian investors can start investing in Pavmed (PAVM) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Pavmed stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Pavmed share’s latest price of $0.48 as on August 25, 2025 at 7:38 PM IST, you will get 20.8333 shares of Pavmed. Learn more about fractional shares .

What are the returns that Pavmed has given to Indian investors in the last 5 years?

Pavmed stock has given -98.43% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?